142 related articles for article (PubMed ID: 28404911)
1. Flattened microvessel independently predicts poor prognosis of patients with non-small cell lung cancer.
Fang L; He Y; Tong Y; Hu L; Xin W; Liu Y; Zhong L; Zhang Y; Huang P
Oncotarget; 2017 May; 8(18):30092-30099. PubMed ID: 28404911
[TBL] [Abstract][Full Text] [Related]
2. Elevated proportion of collapsed microvessels indicate poor survival outcome in patients with non-small cell lung cancer.
Tong YH; He Y; Hu LY; Liu YJ; Zheng XW; Sun J; Song Y; Zhang YW; Fang L; Huang P
Tumori; 2019 Dec; 105(6):494-500. PubMed ID: 31478461
[TBL] [Abstract][Full Text] [Related]
3. Tumor angiogenesis in predicting the survival of patients with stage I lung cancer.
Medetoglu B; Gunluoglu MZ; Demir A; Melek H; Buyukpinarbasili N; Fener N; Dincer SI
J Thorac Cardiovasc Surg; 2010 Nov; 140(5):996-1000. PubMed ID: 20708755
[TBL] [Abstract][Full Text] [Related]
4. Angiogenesis as a prognostic indicator of survival in non-small-cell lung carcinoma: a prospective study.
Fontanini G; Lucchi M; Vignati S; Mussi A; Ciardiello F; De Laurentiis M; De Placido S; Basolo F; Angeletti CA; Bevilacqua G
J Natl Cancer Inst; 1997 Jun; 89(12):881-6. PubMed ID: 9196255
[TBL] [Abstract][Full Text] [Related]
5. Mast cell phenotypes and microvessels in non-small cell lung cancer and its prognostic significance.
Carlini MJ; Dalurzo MC; Lastiri JM; Smith DE; Vasallo BC; Puricelli LI; Lauría de Cidre LS
Hum Pathol; 2010 May; 41(5):697-705. PubMed ID: 20040391
[TBL] [Abstract][Full Text] [Related]
6. [The influence of microvessel density in the tumor on the prognosis in patients with stage I-II non-small cell lung cancer after surgical treatment].
Kolesnik AP; Shevchenko AI; Tumanskiĭ VA; Evseev AV; Shishkin MA
Vopr Onkol; 2013; 59(6):735-9. PubMed ID: 24624783
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
8. Angiogenesis as a predictor of survival after surgical resection for stage I non-small-cell lung cancer.
Duarte IG; Bufkin BL; Pennington MF; Gal AA; Cohen C; Kosinski AS; Mansour KA; Miller JI
J Thorac Cardiovasc Surg; 1998 Mar; 115(3):652-8; discussion 658-9. PubMed ID: 9535454
[TBL] [Abstract][Full Text] [Related]
9. Comparative evaluation of angiogenesis assessment with anti-factor-VIII and anti-CD31 immunostaining in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Theodossiou D; Barbatis K; O'Byrne K; Harris AL; Gatter KC
Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2485-92. PubMed ID: 9815651
[TBL] [Abstract][Full Text] [Related]
10. Association of immunoreactive hepatocyte growth factor with poor survival in resectable non-small cell lung cancer.
Siegfried JM; Weissfeld LA; Singh-Kaw P; Weyant RJ; Testa JR; Landreneau RJ
Cancer Res; 1997 Feb; 57(3):433-9. PubMed ID: 9012470
[TBL] [Abstract][Full Text] [Related]
11. Decreased tumstatin-mRNA is associated with poor outcome in patients with NSCLC.
Luo YQ; Ming Z; Zhao L; Yao LJ; Dong H; Du JP; Wu SZ; Hu W
IUBMB Life; 2012 May; 64(5):423-31. PubMed ID: 22473740
[TBL] [Abstract][Full Text] [Related]
12. Elevated expression of carcinoembryonic antigen-related cell adhesion molecule 1 (CEACAM-1) is associated with increased angiogenic potential in non-small-cell lung cancer.
Dango S; Sienel W; Schreiber M; Stremmel C; Kirschbaum A; Pantel K; Passlick B
Lung Cancer; 2008 Jun; 60(3):426-33. PubMed ID: 18215438
[TBL] [Abstract][Full Text] [Related]
13. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
14. Interleukin-37 suppresses tumor growth through inhibition of angiogenesis in non-small cell lung cancer.
Ge G; Wang A; Yang J; Chen Y; Yang J; Li Y; Xue Y
J Exp Clin Cancer Res; 2016 Jan; 35():13. PubMed ID: 26791086
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.
Yuan A; Yang PC; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 2000 Nov; 162(5):1957-63. PubMed ID: 11069840
[TBL] [Abstract][Full Text] [Related]
16. A meta-analysis of STAT3 and phospho-STAT3 expression and survival of patients with non-small-cell lung cancer.
Xu YH; Lu S
Eur J Surg Oncol; 2014 Mar; 40(3):311-7. PubMed ID: 24332948
[TBL] [Abstract][Full Text] [Related]
17. Cluster analysis of p-glycoprotein, c-erb-B2 and P53 in relation to tumor histology strongly indicates prognosis in patients with operable non-small cell lung cancer.
Bozcuk H; Gumus A; Ozbilim G; Sarper A; Kucukosmanoglu I; Ozbudak IH; Artac M; Ozdogan M; Samur M; Kaya A; Savas B
Med Sci Monit; 2005 Jun; 11(6):HY11-20. PubMed ID: 15917726
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival.
Fontanini G; De Laurentiis M; Vignati S; Chinè S; Lucchi M; Silvestri V; Mussi A; De Placido S; Tortora G; Bianco AR; Gullick W; Angeletti CA; Bevilacqua G; Ciardiello F
Clin Cancer Res; 1998 Jan; 4(1):241-9. PubMed ID: 9516978
[TBL] [Abstract][Full Text] [Related]
19. Angiogenesis and molecular biologic substaging in patients with stage I non-small cell lung cancer.
Harpole DH; Richards WG; Herndon JE; Sugarbaker DJ
Ann Thorac Surg; 1996 May; 61(5):1470-6. PubMed ID: 8633961
[TBL] [Abstract][Full Text] [Related]
20. Expression of TLR9 in tumor-infiltrating mononuclear cells enhances angiogenesis and is associated with a worse survival in lung cancer.
Belmont L; Rabbe N; Antoine M; Cathelin D; Guignabert C; Kurie J; Cadranel J; Wislez M
Int J Cancer; 2014 Feb; 134(4):765-77. PubMed ID: 23913633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]